Orthofix stock.

Dec 1, 2023 · According to the issued ratings of 3 analysts in the last year, the consensus rating for Orthofix Medical stock is Hold based on the current 3 hold ratings for OFIX. The average twelve-month price prediction for Orthofix Medical is $14.00 with a high price target of $16.00 and a low price target of $12.00. Learn more on OFIX's analyst rating ... Real time Orthofix Medical (OFIX) stock price quote, stock graph, news & analysis. Nov 29, 2023 · The Orthofix International N.V. stock price gained 0.267% on the last trading day (Wednesday, 29th Nov 2023), rising from $11.23 to $11.26. During the last trading day the stock fluctuated 2.93% from a day low at $11.25 to a day high of $11.58. The price has risen in 8 of the last 10 days and is up by 7.6% over the past 2 weeks. NEW YORK, NY / ACCESSWIRE / October 23, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Orthofix Medical Inc. ("Orthofix" or "the Company") (NASDAQ:OFIX). Investors who purchased Orthofix securities are encouraged to obtain additional information and assist the investigation by …

Orthofix Medical Inc. (OFIX) Stock Price, Quote, News & Analysis Save 45%! Get early access to our annual Black Friday Sale » OFIX Orthofix Medical Inc. Stock Price & …13 hours ago · Orthofix Medical Inc. (NASDAQ:OFIX) shares fell 5.4% to $10.52 in pre-market trading. Sealed Air will replace Orthofix Medical in the S&P SmallCap 600, effective prior to the open of trading on ... Orthofix Medical Inc. , a leading global spine and orthopedics company, today announced that it will host an Analyst Teach-In Meeting in Lewisville, TX on Monday, March 13, 2023 from 2:30 -...

Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. ... Stock Orthofix Medical Inc. - Nasdaq . News Orthofix Medical Inc. Transcript : Orthofix Medical Inc., Q2 2023 Earnings Call, Aug 08, 2023. CATEGORIES. …

On this news, Orthofix's stock price fell $5.62 per share, or 30.17%, to close at $13.01 per share on September 12, 2023. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation.Description. Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair ...Shares of Orthofix Medical (. OFIX Quick Quote. OFIX - Free Report) have plunged 4.5% since the release of its third-quarter earnings on Nov 8. The company delivered third-quarter 2023 adjusted ...Third quarter net sales of $114 million, an increase of 1% on a reported basis and 5% on a constant currency basis over prior year Global Orthopedics net sales growth of 19% on a constant currency basis driven by commercial channel investments Biologics net sales growth of 8% driven by new product introductions Bone Growth Therapies net …Sep 13, 2023 · Orthofix’s stock has lost 36.6% year to date, while the S&P 500 index SPX, +0.18% has gained 16.2%. Advertisement. Advertisement. Partner Center. Advertisement. Advertisement.

Boston, Massachusetts--(Newsfile Corp. - October 17, 2023) - Block & Leviton is investigating Orthofix Medical, Inc. (NASDAQ: OFIX) for potential securities law violations.

Orthofix Medical ( NASDAQ: OFIX) rose 7.3% after disclosing it received an unsolicited takeover interest from two private equity firms for $23/share in cash. Orthofix ( OFIX) said it received a ...

Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics.Orthofix Medical Inc. Common Stock (DE) (OFIX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Oct 14, 2023 · This decision led to certain analysts downgrading Orthofix, causing a significant drop in the company's stock price on that day. Please visit our website to review more information and submit your ... New York, New York--(Newsfile Corp. - November 9, 2023) - Pomerantz LLP is investigating claims on behalf of investors of Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX). Such ...Orthofix’s recent financial performance also informs the Hold rating. While the company has shown some growth, with a modest year-over-year increase in sales, it has …

Oct 12, 2023 · “Orthofix is a leader in both the demineralized bone matrices (DBM) and cellular allograft markets, and the launch of OsteoCove significantly strengthens our biologics portfolio and builds on our mission to deliver best-in-class products in every major bone grafting category,” said Tyler Lipschultz, President, Orthofix Global Biologics. Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t...SeaSpine shares ceased trading on the Nasdaq Global Select Market at 8:00 p.m. Eastern time on January 4, 2023, and holders of SeaSpine common stock are receiving 0.4163 shares of Orthofix common ...August 08, 2023 at 06:19 pm EDT. LEWISVILLE, Texas (AP) — LEWISVILLE, Texas (AP) — Orthofix Medical Inc. (OFIX) on Tuesday reported a loss of $39.4 million in its second quarter. On a per-share basis, the Lewisville, Texas -based company said it had a loss of $1.07. Earnings, adjusted for non-recurring costs and costs related to mergers and ...Nov 25, 2023 · If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). SeaSpine shares will cease trading on the Nasdaq Global Select Market at 8:00 p.m. Eastern Standard Time today, and holders of SeaSpine common stock will receive 0.4163 shares of Orthofix common stock for each share of SeaSpine common stock owned. Orthofix, as the corporate parent entity in the combined company structure, will continue to trade ...

SeaSpine shares will cease trading on the Nasdaq Global Select Market at 8:00 p.m. Eastern Standard Time today, and holders of SeaSpine common stock will receive 0.4163 shares of Orthofix common ...LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, announced today …

U.S. stock futures traded lower this morning, with the Dow Jones futures falling more than 50 points on Monday. ... Orthofix Medical Inc. OFIX shares fell 5.4% to $10.52 in pre-market trading ...Director James F. Hinrichs was responsible for acquiring 7,500 shares of Orthofix Medical stock in a transaction that took place on Thursday, September 14th. The average price per share was $13.47, resulting in a total transaction value of $101,025.00. Following this purchase, Director Hinrichs now possesses 86,153 shares of the …Orthofix Medical Inc. (NASDAQ:OFIX) entered into a new four-year financing agreement with a borrowing capacity of up to $150 million. The company reported net sales of $184.0 million, a 61% increase on a reported basis and an 8% increase on a pro forma basis. Adjusted EBITDA was $13.5 million, representing 36% sequential growth over the …NEW YORK, Nov. 25, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Orthofix Medical Inc. ("Orthofix" or the "Company") (NASDAQ: OFIX). Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California ...Nov 8, 2023 · If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). há 8 horas ... Orthofix Medical Inc (OFIX) stock has fallen -43.67% over the last 12 months, and the average rating from Wall Street analysts is a Buy.Orthofix Medical Inc. operates spine and orthopedics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through Global Spine and Global Orthopedics segments. The Global Spine segment comprises the bone growth therapies products, which manufactures and distributes bone …

If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

About Orthofix. Orthofix is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions, and a leading surgical navigation system. Its products are distributed in approximately 68 countries worldwide.

DEAR SHAREHOLDERS, I am extremely proud of how Orthofix upheld our commitments to surgeons and patients in 2021, while making important investments in our new product pipeline and business operations, all during the continuing challenges of the ongoing global pandemic. We accelerated our strategic plan by investing in our …Discover Orthofix Medical's earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. ... Orthofix stock falls amid SeaSpine merger despite rise in prelim Q3 revenue Oct 11. Orthofix Medical Inc. Revises Financial Guidance for the Full Year 2022 Aug 06. Second quarter …LEWISVILLE, Texas & CARLSBAD, Calif.--(BUSINESS WIRE)-- Orthofix (NASDAQ: OFIX), a global medical device company with a spine and orthopedics focus, and SeaSpine (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that John Bostjancic will serve as Chief Financial Officer (CFO) for the new combined company ...17 de out. de 2023 ... Our experts picked 7 Zacks Rank #1 Strong Buy stocks with the best chance to skyrocket within the next 30-90 days. Recent stocks from this ...Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) investors concerning the Company’s possible violations of the federal securities laws.Orthofix Medical Inc. announced that Massimo Calafiore has been named incoming President and Chief Executive Officer. Mr. Calafiore is currently Chief Executive Officer of LimaCorporate S.p.A., and his appointment to Orthofix is expected to be effective in early 2024, following the completion of LimaCorporate?s previously announced …Nov 8, 2023 · If you purchased or acquired securities in Orthofix stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Reported on 11/8/23. Get the latest Orthofix Medical Inc (OFIX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and ... Oct 12, 2023 · “Orthofix is a leader in both the demineralized bone matrices (DBM) and cellular allograft markets, and the launch of OsteoCove significantly strengthens our biologics portfolio and builds on our mission to deliver best-in-class products in every major bone grafting category,” said Tyler Lipschultz, President, Orthofix Global Biologics. Jan 9, 2023 · SeaSpine shares ceased trading on the Nasdaq Global Select Market at 8:00 p.m. Eastern time on January 4, 2023, and holders of SeaSpine common stock are receiving 0.4163 shares of Orthofix common stock for each share of SeaSpine common stock previously owned. Orthofix, as the corporate parent entity in the combined company structure, will ...

Orthofix Medical Stock Up 3.4 %. Shares of NASDAQ:OFIX opened at $11.19 on Tuesday. Orthofix Medical has a 1 year low of $9.57 and a 1 year high of $23.19. The company has a market cap of $411.31 million, a PE ratio of -2.87 and a beta of 1.05. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.58 and a quick ratio of 1.13.Orthofix currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader medical space are Haemonetics HAE , Quanterix QTRX and Intuitive Surgical ISRG , each carrying a Zacks ...The stock sells at ~1x forward sales and has created marginal value above its net asset value ($1.12 for every $1 invested, to be precise). Investors have priced the company at just 1.12x the ...Instagram:https://instagram. stock prop trading firmsansheiser busch stockintuit stock valuegood credit card for restaurants Institutional investors purchased a net $2.8 million shares of OFIX during the quarter ended June 2019 and now own 96.43% of the total shares outstanding. This ... top healthcare stocksstock price x Orthofix Medical Inc. (OFIX) is a leading global spine and orthopedics company that provides products and services for musculoskeletal health. The stock price, news, quote …18 de out. de 2023 ... Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its third quarter ... uti price (RTTNews) - Orthofix Medical Inc. (OFIX) announced the full U.S. commercial launch of the WaveForm L Lateral Lumbar Interbody System. The 3D-printed WaveForm L features a porous structure that ...Orthofix’s stock has worst day in nearly 30 years after 3 top executives are fired for ‘offensive conduct’ (MarketWatch) Orthofix Medical Inc. investors suffered their worst day in nearly 30 years on Tuesday, after the spine and orthopedics company fired three top executives “for cause.”. The company OFIX, 2.31% said following an ...LEWISVILLE, Texas, September 12, 2023--Orthofix Medical Inc. (NASDAQ: OFIX), a leading global spine and orthopedics company, today announced that Catherine Burzik, Chair of the Orthofix Board of ...